Novo Nordisk A/S reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was DKK 35,622 million compared to DKK 30,927 million a year ago. Net income was DKK 12,119 million compared to DKK 10,298 million a year ago. For the nine months, sales was DKK 102,467 million compared to DKK 94,808 million a year ago. Net income was DKK 36,865 million compared to DKK 32,820 million a year ago.